<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 0pt; margin-bottom: 0pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM 8-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 0pt; margin-bottom: 0pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Current Report</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Pursuant to Section 13 or 15(d) of the</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Securities Exchange Act of 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Date of Report (Date of earliest event
reported): June 19, 2012 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 0pt; margin-bottom: 0pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>VRINGO, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Exact Name of Registrant as Specified
in its Charter)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 0pt; margin-bottom: 0pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-family: Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 33%; font-size: 10pt; font-weight: bold; text-align: center">Delaware</TD>
    <TD STYLE="width: 33%; font-size: 10pt; font-weight: bold; text-align: center">001-34785</TD>
    <TD STYLE="width: 33%; font-size: 10pt; font-weight: bold; text-align: center">20-4988129</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(State or other jurisdiction</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>of incorporation)</B></P></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Commission</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>File Number)</B></P></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(I.R.S. Employer</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Identification No.)</B></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>44 W. 28th Street</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>New York, New York 10001</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Address of Principal Executive Offices
and Zip Code)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Registrant&rsquo;s telephone number,
including area code: (646) 525-4319</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 0pt; margin-bottom: 0pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Wingdings; color: black"><FONT STYLE="font-family: Wingdings">&#120;</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9;<FONT STYLE="color: black">Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Wingdings; color: black">&uml;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9;<FONT STYLE="color: black">Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Wingdings; color: black">&uml;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9;<FONT STYLE="color: black">Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Wingdings; color: black">&uml;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9;<FONT STYLE="color: black">Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 50%">&nbsp;</TD><TD STYLE="text-align: right; width: 50%"></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 1in; text-align: left"><B>Item 8.01</B></TD><TD STYLE="text-align: justify"><B>Other Events.</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As previously disclosed, on March 12, 2012,
Vringo, Inc. (the &ldquo;<U>Company</U>&rdquo;), VIP Merger Sub, Inc., a wholly-owned subsidiary of the Company (&ldquo;<U>Merger
Sub</U>&rdquo;), and Innovate/Protect, Inc. (&ldquo;<U>Innovate/Protect</U>&rdquo;) entered into a merger agreement (as may be
amended or modified, the &ldquo;<U>Merger Agreement</U>&rdquo;), pursuant to which Innovate/Protect will merge with and into Merger
Sub, with Merger Sub surviving the merger as a wholly-owned subsidiary of the Company (the &ldquo;<U>Merger</U>&rdquo;). The consummation
of the Merger with Innovate/Protect is subject to stockholders&rsquo; approval and other closing conditions. A copy of the Merger
Agreement was filed as Exhibit 2.1 to the Company&rsquo;s Current Report on Form 8-K filed with the Securities and Exchange Commission
(the &ldquo;<U>SEC</U>&rdquo;) on March 14, 2012 and is incorporated herein by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="color: black">This Current
Report on Form 8-K is being filed to provide (i) the </FONT>unaudited pro forma consolidated statement of operation for the three
month period ended March 31, 2012, (ii) the unaudited pro forma consolidated balance sheets, as of March 31, 2012 and (iii) the
unaudited pro forma consolidated statement of operation, for the period from June 8, 2011 (date of inception of Innovate/Protect)
through December 31, 2011.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company has filed with the SEC a registration
statement on Form S-3 for the resale of up to 2,672,756 shares and subsequently amended to 2,526,289 shares of common stock issued
and issuable upon exercise of warrants held by certain security holders named therein which has not yet become effective. No securities
may be sold nor offers to buy securities be accepted prior to the time the registration statement becomes effective.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Important Additional Information Will Be Filed with the SEC
</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This report does not
constitute an offer to sell or the solicitation of an offer to buy any securities of the Company, or Innovate/Protect or the solicitation
of any vote or approval. In connection with the proposed Merger, the Company filed a Registration Statement on Form S-4 with the
SEC on April 6, 2012, subsequently amended on May 17, 2012, June 1, 2012 and June 12, 2012, which includes a preliminary proxy
statement/prospectus of the Company. These materials are not yet final and will be further amended. The proxy statement/prospectus
contains important information about the Company, Innovate/Protect, the Merger and related matters. The Company will mail or otherwise
deliver the proxy statement/prospectus to its stockholders and the stockholders of Innovate/Protect once it is final. <B>Investors
and security holders of the Company and Innovate/Protect are urged to read carefully the proxy statement/prospectus relating to
the merger (including any amendments or supplements thereto) in its entirety when it is available, because it will contain important
information about the Company, Innovate/Protect and the proposed transaction.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Investors and security
holders of the Company will be able to obtain free copies of the proxy statement/prospectus for the proposed merger (when it is
available) and other documents filed with the SEC by the Company through the website maintained by the SEC at www.sec.gov. In addition,
investors and security holders of the Company and Innovate/Protect will be able to obtain free copies of the proxy statement/prospectus
for the proposed merger (when it is available) by contacting Vringo, Inc., Attn.: Cliff Weinstein, VP Corporate Development, at
44 W. 28th Street, New York, New York 10001, or by e-mail at cliff@vringo.com. Investors and security holders of Innovate/Protect
will also be able to obtain free copies of the proxy statement/prospectus for the merger by contacting Innovate/Protect, Attn.:
Chief Operating Officer, 380 Madison Avenue, 22nd Floor, New York, NY 10017, or by e-mail at info@innovateprotect.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 50%">&nbsp;</TD><TD STYLE="text-align: right; width: 50%"></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Cautionary Note Regarding Forward-Looking
Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Statements in this
report regarding the proposed Merger between the Company and Innovate/Protect; the expected timetable for completing the transaction;
the potential value created by the proposed Merger for the Company&rsquo;s and Innovate/Protect&rsquo;s stockholders; the potential
of the combined companies&rsquo; technology platform; the Company&rsquo;s respective or combined ability to raise capital to fund
our combined operations and business plan; the continued listing of the Company&rsquo;s or the combined company&rsquo;s securities
on the NYSE Amex; market acceptance of the Company&rsquo;s products; our collective ability to protect our intellectual property
rights; competition from other providers and products; our ability to license and monetize the patents owned by Innovate/Protect,
including the outcome of the litigation against online search firms and other companies; the combined company&rsquo;s management
and board of directors; and any other statements about the Company&rsquo;s or Innovate/Protect&rsquo;s management teams&rsquo;
future expectations, beliefs, goals, plans or prospects constitute forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995. Any statements that are not statements of historical fact (including statements containing
the words &ldquo;believes,&rdquo; &ldquo;plans,&rdquo; &ldquo;could,&rdquo; &ldquo;anticipates,&rdquo; &ldquo;expects,&rdquo; &ldquo;estimates,&rdquo;
&ldquo;plans,&rdquo; &ldquo;should,&rdquo; &ldquo;target,&rdquo; &ldquo;will,&rdquo; &ldquo;would&rdquo; and similar expressions)
should also be considered to be forward-looking statements. There are a number of important factors that could cause actual results
or events to differ materially from those indicated by such forward-looking statements, including: the risk that the Company and
Innovate/Protect may not be able to complete the proposed transaction; the inability to realize the potential value created by
the proposed merger for the Company&rsquo;s and Innovate/Protect&rsquo;s stockholders; our respective or combined inability to
raise capital to fund our combined operations and business plan; the Company&rsquo;s or the combined company&rsquo;s inability
to maintain the listing of our securities on the NYSE Amex; the potential lack of market acceptance of the Company&rsquo;s products;
our collective inability to protect our intellectual property rights; potential competition from other providers and products;
our inability to license and monetize the patents owned by Innovate/Protect, including the outcome of the litigation against online
search firms and other companies; and other risks and uncertainties more fully described in the Company&rsquo;s Annual Report on
Form 10-K for the year ended December 31, 2011 and its Quarterly Report on Form 10-Q for the quarter ended March 31, 2012, as filed with the SEC, as well as the other filings that the Company makes with the SEC. Investors and stockholders are also urged
to read the risk factors set forth in the proxy statement/prospectus carefully.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, the statements
in this report reflect our expectations and beliefs as of the date of this report. The Company anticipates that subsequent events
and developments will cause its expectations and beliefs to change. However, while the Company may elect to update these forward-looking
statements publicly at some point in the future, the company specifically disclaims any obligation to do so, whether as a result
of new information, future events or otherwise. These forward-looking statements should not be relied upon as representing the
Company&rsquo;s views as of any date after the date of this release.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 1in; text-align: left"><B>Item 9.01</B></TD><TD STYLE="text-align: justify"><B>Financial Statements and Exhibits.</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left">(b)</TD><TD STYLE="text-align: justify">Pro Forma Financial Information.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The unaudited pro forma combined financial
statements reflecting the Merger are filed herewith as Exhibit 99.1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left">(d)</TD><TD STYLE="text-align: justify">Exhibits.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="color: black">99.1</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: black">Unaudited Pro Forma Combined
Financial Statements</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 50%">&nbsp;</TD><TD STYLE="text-align: right; width: 50%"></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 23.1pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 23.1pt">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-family: Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold">VRINGO, INC.</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">Dated: June 19, 2012</TD>
    <TD STYLE="font-size: 10pt">By:</TD>
    <TD COLSPAN="2">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; border-bottom: black 0.75pt solid">/s/ Andrew D. Perlman</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 46%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 4%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 8%; font-size: 10pt">Name:</TD>
    <TD STYLE="width: 42%; font-size: 10pt">Andrew D. Perlman</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">Title:</TD>
    <TD STYLE="font-size: 10pt">Chief Executive Officer and President</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 50%">&nbsp;</TD><TD STYLE="text-align: right; width: 50%"></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT INDEX</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="color: black">99.1</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="color: black">Unaudited Pro Forma Combined
Financial Statements</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: Red">&nbsp;</P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 50%">&nbsp;</TD><TD STYLE="text-align: right; width: 50%"></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
[{"type": "8-K", "sequence": "1", "filename": "v316079_8k.htm", "description": "CURRENT REPORT", "secsgml_size_bytes": 25546}]
{"company-data": {"conformed-name": "Vringo Inc", "cik": "0001410428", "assigned-sic": "4899", "irs-number": "000000000", "state-of-incorporation": "DE"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-34785", "film-number": "12915860"}, "business-address": {"street1": "18 EAST 16TH STREET", "city": "NEW YORK", "state": "NY", "zip": "10003", "phone": "646-861-5575"}, "mail-address": {"street1": "18 EAST 16TH STREET", "city": "NEW YORK", "state": "NY", "zip": "10003"}}
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event
reported): June 19, 2012
VRINGO, INC.
(Exact Name of Registrant as Specified
in its Charter)
Delaware
001-34785
20-4988129
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(I.R.S. Employer
Identification No.)
44 W. 28th Street
New York, New York 10001
(Address of Principal Executive Offices
and Zip Code)
Registrant's telephone number,
including area code: (646) 525-4319
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
x
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01
Other Events.
As previously disclosed, on March 12, 2012,
Vringo, Inc. (the "
Company
"), VIP Merger Sub, Inc., a wholly-owned subsidiary of the Company ("
Merger
Sub
"), and Innovate/Protect, Inc. ("
Innovate/Protect
") entered into a merger agreement (as may be
amended or modified, the "
Merger Agreement
"), pursuant to which Innovate/Protect will merge with and into Merger
Sub, with Merger Sub surviving the merger as a wholly-owned subsidiary of the Company (the "
Merger
"). The consummation
of the Merger with Innovate/Protect is subject to stockholders' approval and other closing conditions. A copy of the Merger
Agreement was filed as Exhibit 2.1 to the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission
(the "
SEC
") on March 14, 2012 and is incorporated herein by reference.
This Current
Report on Form 8-K is being filed to provide (i) the
unaudited pro forma consolidated statement of operation for the three
month period ended March 31, 2012, (ii) the unaudited pro forma consolidated balance sheets, as of March 31, 2012 and (iii) the
unaudited pro forma consolidated statement of operation, for the period from June 8, 2011 (date of inception of Innovate/Protect)
through December 31, 2011.
The Company has filed with the SEC a registration
statement on Form S-3 for the resale of up to 2,672,756 shares and subsequently amended to 2,526,289 shares of common stock issued
and issuable upon exercise of warrants held by certain security holders named therein which has not yet become effective. No securities
may be sold nor offers to buy securities be accepted prior to the time the registration statement becomes effective.
Important Additional Information Will Be Filed with the SEC
This report does not
constitute an offer to sell or the solicitation of an offer to buy any securities of the Company, or Innovate/Protect or the solicitation
of any vote or approval. In connection with the proposed Merger, the Company filed a Registration Statement on Form S-4 with the
SEC on April 6, 2012, subsequently amended on May 17, 2012, June 1, 2012 and June 12, 2012, which includes a preliminary proxy
statement/prospectus of the Company. These materials are not yet final and will be further amended. The proxy statement/prospectus
contains important information about the Company, Innovate/Protect, the Merger and related matters. The Company will mail or otherwise
deliver the proxy statement/prospectus to its stockholders and the stockholders of Innovate/Protect once it is final.
Investors
and security holders of the Company and Innovate/Protect are urged to read carefully the proxy statement/prospectus relating to
the merger (including any amendments or supplements thereto) in its entirety when it is available, because it will contain important
information about the Company, Innovate/Protect and the proposed transaction.
Investors and security
holders of the Company will be able to obtain free copies of the proxy statement/prospectus for the proposed merger (when it is
available) and other documents filed with the SEC by the Company through the website maintained by the SEC at www.sec.gov. In addition,
investors and security holders of the Company and Innovate/Protect will be able to obtain free copies of the proxy statement/prospectus
for the proposed merger (when it is available) by contacting Vringo, Inc., Attn.: Cliff Weinstein, VP Corporate Development, at
44 W. 28th Street, New York, New York 10001, or by e-mail at cliff@vringo.com. Investors and security holders of Innovate/Protect
will also be able to obtain free copies of the proxy statement/prospectus for the merger by contacting Innovate/Protect, Attn.:
Chief Operating Officer, 380 Madison Avenue, 22nd Floor, New York, NY 10017, or by e-mail at info@innovateprotect.com.
Cautionary Note Regarding Forward-Looking
Statements
Statements in this
report regarding the proposed Merger between the Company and Innovate/Protect; the expected timetable for completing the transaction;
the potential value created by the proposed Merger for the Company's and Innovate/Protect's stockholders; the potential
of the combined companies' technology platform; the Company's respective or combined ability to raise capital to fund
our combined operations and business plan; the continued listing of the Company's or the combined company's securities
on the NYSE Amex; market acceptance of the Company's products; our collective ability to protect our intellectual property
rights; competition from other providers and products; our ability to license and monetize the patents owned by Innovate/Protect,
including the outcome of the litigation against online search firms and other companies; the combined company's management
and board of directors; and any other statements about the Company's or Innovate/Protect's management teams'
future expectations, beliefs, goals, plans or prospects constitute forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995. Any statements that are not statements of historical fact (including statements containing
the words "believes," "plans," "could," "anticipates," "expects," "estimates,"
"plans," "should," "target," "will," "would" and similar expressions)
should also be considered to be forward-looking statements. There are a number of important factors that could cause actual results
or events to differ materially from those indicated by such forward-looking statements, including: the risk that the Company and
Innovate/Protect may not be able to complete the proposed transaction; the inability to realize the potential value created by
the proposed merger for the Company's and Innovate/Protect's stockholders; our respective or combined inability to
raise capital to fund our combined operations and business plan; the Company's or the combined company's inability
to maintain the listing of our securities on the NYSE Amex; the potential lack of market acceptance of the Company's products;
our collective inability to protect our intellectual property rights; potential competition from other providers and products;
our inability to license and monetize the patents owned by Innovate/Protect, including the outcome of the litigation against online
search firms and other companies; and other risks and uncertainties more fully described in the Company's Annual Report on
Form 10-K for the year ended December 31, 2011 and its Quarterly Report on Form 10-Q for the quarter ended March 31, 2012, as filed with the SEC, as well as the other filings that the Company makes with the SEC. Investors and stockholders are also urged
to read the risk factors set forth in the proxy statement/prospectus carefully.
In addition, the statements
in this report reflect our expectations and beliefs as of the date of this report. The Company anticipates that subsequent events
and developments will cause its expectations and beliefs to change. However, while the Company may elect to update these forward-looking
statements publicly at some point in the future, the company specifically disclaims any obligation to do so, whether as a result
of new information, future events or otherwise. These forward-looking statements should not be relied upon as representing the
Company's views as of any date after the date of this release.
Item 9.01
Financial Statements and Exhibits.
(b)
Pro Forma Financial Information.
The unaudited pro forma combined financial
statements reflecting the Merger are filed herewith as Exhibit 99.1.
(d)
Exhibits.
99.1
Unaudited Pro Forma Combined
Financial Statements
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
VRINGO, INC.
Dated: June 19, 2012
By:
/s/ Andrew D. Perlman
Name:
Andrew D. Perlman
Title:
Chief Executive Officer and President
EXHIBIT INDEX
99.1
Unaudited Pro Forma Combined
Financial Statements